BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 7490915)

  • 1. DNA fluorescent probes for diagnosis of velocardiofacial and related syndromes.
    Crifasi PA; Michels VV; Driscoll DJ; Jalal SM; Dewald GW
    Mayo Clin Proc; 1995 Dec; 70(12):1148-53. PubMed ID: 7490915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CATCH 22: deletion of locus 22q11 in velocardiofacial syndrome, DiGeorge anomaly, and nonsyndromic conotruncal defects.
    Hou JW; Wang JK; Tsai WY; Chou CC; Wang TR
    J Formos Med Assoc; 1997 Jun; 96(6):419-23. PubMed ID: 9216164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CATCH 22 syndrome: report of 7 infants with follow-up data and review of the recent advancements in the genetic knowledge of the locus 22q11.
    Sergi C; Serpi M; Müller-Navia J; Schnabel PA; Hagl S; Otto HF; Ulmer HE
    Pathologica; 1999 Jun; 91(3):166-72. PubMed ID: 10536461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microdeletion of 22q11 (CATCH 22) in children with conotruncal heart defect and extracardiac malformations.
    Alikaşifoğlu M; Malkoç N; Ceviz N; Ozme S; Uludoğan S; Tunçbilek E
    Turk J Pediatr; 2000; 42(3):215-8. PubMed ID: 11105620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CATCH 22 Syndrome.
    Yonehara Y; Nakatsuka T; Ichioka S; Sasaki N; Kobayashi T
    J Craniofac Surg; 2002 Sep; 13(5):623-6. PubMed ID: 12218787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confirmation that the conotruncal anomaly face syndrome is associated with a deletion within 22q11.2.
    Matsuoka R; Takao A; Kimura M; Imamura S; Kondo C; Joh-o K; Ikeda K; Nishibatake M; Ando M; Momma K
    Am J Med Genet; 1994 Nov; 53(3):285-9. PubMed ID: 7856665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microdeletion 22q11 in complex cardiovascular malformations.
    Mehraein Y; Wippermann CF; Michel-Behnke I; Nhan Ngo TK; Hillig U; Giersberg M; Aulepp U; Barth H; Fritz B; Rehder H
    Hum Genet; 1997 Apr; 99(4):433-42. PubMed ID: 9099830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic basis of DiGeorge and velocardiofacial syndromes.
    Driscoll DA
    Curr Opin Pediatr; 1994 Dec; 6(6):702-6. PubMed ID: 7849818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome 22q11.2 microdeletions in velocardiofacial syndrome patients with widely variable manifestations.
    Ravnan JB; Chen E; Golabi M; Lebo RV
    Am J Med Genet; 1996 Dec; 66(3):250-6. PubMed ID: 8985481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Velo-cardio-facial syndrome associated with chromosome 22 deletions encompassing the DiGeorge locus.
    Scambler PJ; Kelly D; Lindsay E; Williamson R; Goldberg R; Shprintzen R; Wilson DI; Goodship JA; Cross IE; Burn J
    Lancet; 1992 May; 339(8802):1138-9. PubMed ID: 1349369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counselling and prenatal diagnosis.
    Driscoll DA; Salvin J; Sellinger B; Budarf ML; McDonald-McGinn DM; Zackai EH; Emanuel BS
    J Med Genet; 1993 Oct; 30(10):813-7. PubMed ID: 8230155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microdeletion 22q11 and oesophageal atresia.
    Digilio MC; Marino B; Bagolan P; Giannotti A; Dallapiccola B
    J Med Genet; 1999 Feb; 36(2):137-9. PubMed ID: 10051013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microdeletions of chromosomal region 22q11 in patients with congenital conotruncal cardiac defects.
    Goldmuntz E; Driscoll D; Budarf ML; Zackai EH; McDonald-McGinn DM; Biegel JA; Emanuel BS
    J Med Genet; 1993 Oct; 30(10):807-12. PubMed ID: 7901419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kabuki syndrome is not caused by a microdeletion in the DiGeorge/velocardiofacial chromosomal region within 22q 11.2.
    Li M; Zackai EH; Niikawa N; Kaplan P; Driscoll DA
    Am J Med Genet; 1996 Oct; 65(2):101-3. PubMed ID: 8911598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of a 22q11 deletion in patients with conotruncal cardiac malformations: a prospective study.
    Takahashi K; Kido S; Hoshino K; Ogawa K; Ohashi H; Fukushima Y
    Eur J Pediatr; 1995 Nov; 154(11):878-81. PubMed ID: 8582397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical correlation of chromosome 22q11.2 fluorescent in situ hybridization analysis and velocardiofacial syndrome.
    Oh AK; Workman LA; Wong GB
    Cleft Palate Craniofac J; 2007 Jan; 44(1):62-6. PubMed ID: 17214538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychiatric inpatients and chromosome deletions within 22q11.2.
    Sugama S; Namihira T; Matsuoka R; Taira N; Eto Y; Maekawa K
    J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):803-6. PubMed ID: 10567504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of a 22q11.2 deletion in cardiac patients suggests a risk for velopharyngeal incompetence.
    McDonald-McGinn DM; Driscoll DA; Emanuel BS; Goldmuntz E; Clark BJ; Solot C; Cohen M; Schultz P; LaRossa D; Randall P; Zackai EH
    Pediatrics; 1997 May; 99(5):E9. PubMed ID: 9113966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 22q11.2 deletion syndrome: DiGeorge, velocardiofacial, and conotruncal anomaly face syndromes.
    Cuneo BF
    Curr Opin Pediatr; 2001 Oct; 13(5):465-72. PubMed ID: 11801894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Size of 22q deletions in four previously reported patients with conotruncal anomaly face syndrome.
    Pierpont JW; Erickson RP; Thompson FH; Yang JM
    Clin Genet; 1996 Dec; 50(6):545-7. PubMed ID: 9147896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.